CD274 and colorectal carcinoma: Moreover, previous research revealed that the lipid metabolism‐associated prognostic signature has potential as a reliable biomarker for forecasting the effectiveness of chemotherapy and anti‐PD‐L1 therapy in colorectal carcinoma, which includes PROCA1.69